AGREE II: advancing guideline development, reporting and evaluation in health care
Melissa Brouwers1, Michelle E. Kho2,3,4,5,6,7,8,9,10,11, George P. Browman12, Jako Burgers13, Françoise Cluzeau14, Gene Feder15, Béatrice Fervers16, Ian D. Graham17, Jeremy Grimshaw18, Steven Hanna2,3,4,5,6,7,8,9,10,11, John Brazier19, Julie Makarski2,3,4,5,6,7,8,9,10,11, Louise Zitzelsberger20
1McMaster university#TAB#
2Canadian Insti-tutes of Health Re search (Graham), Ottawa, Ont.; the
3From McMaster University (
4Makarski); the Program in Evidence-based Care, Cancer Care Ontario (Brouwers), Hamilton, Ont.; British Columbia Cancer Agency (Browman), Victoria, BC; the Dutch Institute for Healthcare Improvement CBO and IQ Healthcare (Burgers),
5National Institute for Health and Clinical Excellence (Littlejohns), London, UK
6Ottawa Hospital Research Institute (Grimshaw), Ottawa, Ont.; the
7Ottawa (Ont.)
8Radboud University Nijmegen Medical Centre, the Netherlands
9St. George's Univer-sity of London (Cluzeau), London, UK; the
10University of Bristol (Feder), Bris-tol, UK; Unité Cancer et Environement (Fervers),
11Université de Lyon -Centre Léon Bérard, Université Lyon 1, EA 4129, Lyon, France; the
12BRITISH COLUMBIA CANCER AGENCY
13Radboud University Medical Center
14St George's University of London
15Centre for Academic Primary Care
16Univ Lyon 1, Unite Canc & Environm, Univ Lyon, Ctr Berard,EA 4129
17Canadian Institutes of Health Research.
18Ottawa Hosp, Res Inst
19Population Health Sciences
20Canadian Partnership Against Canc